Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.1702
+0.0052
+(3.15%)
At close: 3:21:50 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
11,992
11,992
15,843
13,901
10,443
Operating Income
-11,992
-11,992
-15,843
-13,901
-10,443
Net Non Operating Interest Income Expense
14
14
36
33
3
Other Income Expense
2,084
2,084
-271
--
--
Pretax Income
-9,894
-9,894
-16,078
-13,868
-10,440
Net Income Common Stockholders
-9,894
-9,894
-16,078
-13,868
-10,440
Diluted NI Available to Com Stockholders
-9,894
-9,894
-16,078
-13,868
-10,440
Basic EPS
-4.12
-4.12
-33.63
-38.12
-31.00
Diluted EPS
-4.12
-4.12
-33.63
-38.12
-31.00
Basic Average Shares
2,401
2,401
478
364
336.2500
Diluted Average Shares
2,401
2,401
478
364
336.2500
Total Operating Income as Reported
-11,992
-11,992
-15,843
-13,901
-10,443
Total Expenses
11,992
11,992
15,843
13,901
10,443
Net Income from Continuing & Discontinued Operation
-9,894
-9,894
-16,078
-13,868
-10,440
Normalized Income
-11,978
-11,978
-15,807
-13,868
-10,440
Interest Income
14
14
36
33
3
Net Interest Income
14
14
36
33
3
EBIT
-11,992
-11,992
-15,843
-13,901
-10,443
EBITDA
-11,833
-11,833
-15,665
-13,723
-10,282
Reconciled Depreciation
159
159
178
178
161
Net Income from Continuing Operation Net Minority Interest
-9,894
-9,894
-16,078
-13,868
-10,440
Total Unusual Items Excluding Goodwill
2,084
2,084
-271
--
--
Total Unusual Items
2,084
2,084
-271
--
--
Normalized EBITDA
-13,917
-13,917
-15,394
-13,723
-10,282
12/31/2021 - 3/4/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ADIL Adial Pharmaceuticals, Inc.
0.6900
+5.18%
PBM Psyence Biomedical Ltd.
0.5886
-0.59%
VRAX Virax Biolabs Group Limited
1.1400
+5.56%
HOTH Hoth Therapeutics, Inc.
0.9784
+0.38%
MNPR Monopar Therapeutics Inc.
38.53
+15.26%
AKTX Akari Therapeutics, Plc
1.1000
-4.35%
APM Aptorum Group Limited
0.8789
+2.20%
PXMD PaxMedica, Inc.
0.0002
0.00%
TOVX Theriva Biologics, Inc.
1.1800
+5.36%
PALI Palisade Bio, Inc.
0.6676
-0.33%